InVivo Therapeutics Corporation, along with its affiliate, filed a motion for joint administration of their Chapter 11 bankruptcy cases in the US Bankruptcy Court on February 1, 2024. As per the motion, the debtor seeks the joint administration of the cases of its affiliate, InVivo Therapeutics Holdings Corp., with its own case for administrative and procedural purposes. InVivo Therapeutics Corporation has been proposed as the lead debtor.